| 000 | 01778 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516223012.0 | ||
| 264 | 0 | _c20150825 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1746-6148 | ||
| 024 | 7 |
_a10.1186/1746-6148-10-160 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBreit, Megan N | |
| 245 | 0 | 0 |
_aBiologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines. _h[electronic resource] |
| 260 |
_bBMC veterinary research _cJul 2014 |
||
| 300 |
_a160 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcrylamides _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xgenetics |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aHydrazines _xadministration & dosage |
| 650 | 0 | 4 |
_aKaryopherins _xgenetics |
| 650 | 0 | 4 | _aMelanoma |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xgenetics |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 650 | 0 | 4 | _aExportin 1 Protein |
| 700 | 1 | _aKisseberth, William C | |
| 700 | 1 | _aBear, Misty D | |
| 700 | 1 | _aLandesman, Yosef | |
| 700 | 1 | _aKashyap, Trinayan | |
| 700 | 1 | _aMcCauley, Dilara | |
| 700 | 1 | _aKauffman, Michael G | |
| 700 | 1 | _aShacham, Sharon | |
| 700 | 1 | _aLondon, Cheryl A | |
| 773 | 0 |
_tBMC veterinary research _gvol. 10 _gp. 160 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1746-6148-10-160 _zAvailable from publisher's website |
| 999 |
_c24005067 _d24005067 |
||